A61M 1/3493
Using treatment agents in suspension
Official title: {using treatment agents in suspension}
A61M1/3493 (Using treatment agents in suspension) appears on 47 US grants and 29 published applications in this corpus.
Search patents in A61M- Granted patents
- 47
- Published applications
- 29
- Assignees
- 29
- Inventors
- 64
- Latest grant
- 27 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 2 |
| 2005 | 1 | 2 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 3 | 2 |
| 2014 | 1 | 3 |
| 2015 | 1 | 0 |
| 2016 | 2 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 2 |
| 2019 | 0 | 1 |
| 2020 | 3 | 2 |
| 2021 | 0 | 2 |
| 2022 | 2 | 2 |
| 2023 | 1 | 3 |
| 2024 | 2 | 1 |
| 2025 | 2 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Combined bio-artificial liver support system27 May 2025US 12,311,097 B2Southern Medical University Zhujiang Hospital
- Method and device for treating cancer14 Jan 2025US 12,194,215 B1
- Techniques for removing bound target substances during dialysis9 Apr 2024US 11,951,243 B2Fresenius Medical Care Holdings, Inc.
- Combined bio-artificial liver support system27 Feb 2024US 11,911,552 B2Southern Medical University Zhujiang Hospital
- Phosphor composition having selected surface coatings20 Jun 2023US 11,678,682 B2Immunolight, LLC
- Combined Bio-Artificial Liver Support System9 May 2024US 2024/0148951 A1Southern Medical University Zhujiang Hospital
- Dialysis system for treating sepsis8 Jun 2023US 2023/0173155 A1Centre National de la Recherche Scientifique (CNRS)
- Process and system for acellular therapy9 Mar 2023US 2023/0072523 A1Orgenesis Inc.
- Techniques for removing bound target substances during dialysis5 Jan 2023US 2023/0001064 A1Fresenius Medical Care Holdings, Inc.
- Extracorporeal treatment for aging1 Dec 2022US 2022/0378823 A1Arizona Board of Regents on behalf of Arizona State University
Most cited
By later US patents
- Dialysis instrument with dialysate side pump for moving body fluids336US 4,661,246 AAsh Medical Systems, Inc. · 1987
- Hemofiltration and plasmafiltration devices and methods308US 5,919,369 AHemocleanse, Inc. · 1999
- Hemofiltration and plasmafiltration devices and methods214US 5,536,412 AHemocleanse, Inc. · 1996
- Device and method for extracorporeal blood treatment185US 5,277,820 AHemocleanse, Inc. · 1994
- Specialized perfusion protocol for whole-body hyperthermia156US 5,476,444 AIDT Corporation · 1995